Krka Banned From Selling Donepezil In Norway

Ljubljana, 19 November - Krka Sverige has been banned from producing and marketing a drug containing the active ingredient donepezil. The Slovenian parent company Krka said Wednesday would challenge the temporary injunction issued by the Oslo Executive Court.

The rest of this news item is available to subscribers.
The news item consists of 504 characters (without spaces) or 101 word words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

sz/sm
© STA, 2008